Literature DB >> 26553021

Quality of HbA1c Measurement in Trinidad and Tobago.

Maynika V Rastogi1, Paul Ladenson2, David E Goldstein3, Randie R Little4.   

Abstract

BACKGROUND: Monitoring of HbA1c is the standard of care to assess diabetes control. In Trinidad & Tobago (T&T) there are no existing data on the quality of HbA1c measurement. Our study examined the precision and accuracy of HbA1c testing in T&T.
METHODS: Sets of 10 samples containing blinded duplicates were shipped to laboratories in T&T. This exercise was repeated 6 months later. Precision and accuracy were estimated for each laboratory/method.
RESULTS: T&T methods included immunoassay, capillary electrophoresis, and boronate affinity binding. Most, but not all, laboratories demonstrated acceptable precision and accuracy.
CONCLUSIONS: Continuous oversight of HbA1c testing (eg, through proficiency testing) in T&T is recommended. These results highlight the lack of oversight of HbA1c testing in some developing countries.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  HbA1c; comparison; glycated hemoglobin; proficiency testing

Mesh:

Substances:

Year:  2016        PMID: 26553021      PMCID: PMC5038524          DOI: 10.1177/1932296815609620

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  17 in total

1.  Interlaboratory standardization of measurements of glycohemoglobins.

Authors:  R R Little; H M Wiedmeyer; J D England; A L Wilke; C L Rohlfing; F H Wians; J M Jacobson; V Zellmer; D E Goldstein
Journal:  Clin Chem       Date:  1992-12       Impact factor: 8.327

2.  Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Sverre Sandberg; Callum G Fraser; Andrea Rita Horvath; Rob Jansen; Graham Jones; Wytze Oosterhuis; Per Hyltoft Petersen; Heinz Schimmel; Ken Sikaris; Mauro Panteghini
Journal:  Clin Chem Lab Med       Date:  2015-05       Impact factor: 3.694

3.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Clin Chem       Date:  2011-05-26       Impact factor: 8.327

4.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

5.  Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1996-11-06       Impact factor: 56.272

6.  The response of GHb to stepwise plasma glucose change over time in diabetic patients.

Authors:  Y Tahara; K Shima
Journal:  Diabetes Care       Date:  1993-09       Impact factor: 19.112

Review 7.  Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.

Authors:  Randie R Little; Curt L Rohlfing; David B Sacks
Journal:  Clin Chem       Date:  2010-12-09       Impact factor: 8.327

8.  Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.

Authors:  Andrea Geistanger; Sabine Arends; Christoph Berding; Tadao Hoshino; Jan-Olof Jeppsson; Randie Little; Carla Siebelder; Cas Weykamp
Journal:  Clin Chem       Date:  2008-06-06       Impact factor: 8.327

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  The glycosylation of hemoglobin: relevance to diabetes mellitus.

Authors:  H F Bunn; K H Gabbay; P M Gallop
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.